Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $2.88 billion. The enterprise value is $2.19 billion.
| Market Cap | 2.88B |
| Enterprise Value | 2.19B |
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 122.91 million shares outstanding. The number of shares has increased by 4.21% in one year.
| Current Share Class | 122.91M |
| Shares Outstanding | 122.91M |
| Shares Change (YoY) | +4.21% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 6.16% |
| Owned by Institutions (%) | 85.61% |
| Float | 115.29M |
Valuation Ratios
The trailing PE ratio is 13.71 and the forward PE ratio is 15.54. CPRX's PEG ratio is 1.31.
| PE Ratio | 13.71 |
| Forward PE | 15.54 |
| PS Ratio | 4.93 |
| Forward PS | 4.77 |
| PB Ratio | 3.14 |
| P/TBV Ratio | 3.64 |
| P/FCF Ratio | 12.28 |
| P/OCF Ratio | 12.27 |
| PEG Ratio | 1.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.39, with an EV/FCF ratio of 9.35.
| EV / Earnings | 10.08 |
| EV / Sales | 3.79 |
| EV / EBITDA | 7.39 |
| EV / EBIT | 8.47 |
| EV / FCF | 9.35 |
Financial Position
The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.62 |
| Quick Ratio | 6.19 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 27.52% and return on invested capital (ROIC) is 20.38%.
| Return on Equity (ROE) | 27.52% |
| Return on Assets (ROA) | 17.74% |
| Return on Invested Capital (ROIC) | 20.38% |
| Return on Capital Employed (ROCE) | 28.04% |
| Revenue Per Employee | $3.19M |
| Profits Per Employee | $1.20M |
| Employee Count | 181 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 4.06 |
Taxes
In the past 12 months, CPRX has paid $68.23 million in taxes.
| Income Tax | 68.23M |
| Effective Tax Rate | 23.87% |
Stock Price Statistics
The stock price has increased by +10.57% in the last 52 weeks. The beta is 0.69, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +10.57% |
| 50-Day Moving Average | 21.24 |
| 200-Day Moving Average | 22.04 |
| Relative Strength Index (RSI) | 65.53 |
| Average Volume (20 Days) | 1,428,720 |
Short Selling Information
The latest short interest is 8.49 million, so 6.91% of the outstanding shares have been sold short.
| Short Interest | 8.49M |
| Short Previous Month | 7.92M |
| Short % of Shares Out | 6.91% |
| Short % of Float | 7.36% |
| Short Ratio (days to cover) | 6.04 |
Income Statement
In the last 12 months, CPRX had revenue of $578.20 million and earned $217.56 million in profits. Earnings per share was $1.71.
| Revenue | 578.20M |
| Gross Profit | 480.67M |
| Operating Income | 258.78M |
| Pretax Income | 285.80M |
| Net Income | 217.56M |
| EBITDA | 296.57M |
| EBIT | 258.78M |
| Earnings Per Share (EPS) | $1.71 |
Balance Sheet
The company has $689.89 million in cash and $2.89 million in debt, giving a net cash position of $687.00 million or $5.59 per share.
| Cash & Cash Equivalents | 689.89M |
| Total Debt | 2.89M |
| Net Cash | 687.00M |
| Net Cash Per Share | $5.59 |
| Equity (Book Value) | 920.25M |
| Book Value Per Share | 7.47 |
| Working Capital | 723.72M |
Cash Flow
In the last 12 months, operating cash flow was $234.66 million and capital expenditures -$114,000, giving a free cash flow of $234.54 million.
| Operating Cash Flow | 234.66M |
| Capital Expenditures | -114,000 |
| Free Cash Flow | 234.54M |
| FCF Per Share | $1.91 |
Margins
Gross margin is 83.13%, with operating and profit margins of 44.76% and 37.63%.
| Gross Margin | 83.13% |
| Operating Margin | 44.76% |
| Pretax Margin | 49.43% |
| Profit Margin | 37.63% |
| EBITDA Margin | 51.29% |
| EBIT Margin | 44.76% |
| FCF Margin | 40.56% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.21% |
| Shareholder Yield | -4.21% |
| Earnings Yield | 7.55% |
| FCF Yield | 8.14% |
Analyst Forecast
The average price target for CPRX is $32.60, which is 39.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.60 |
| Price Target Difference | 39.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 11.30% |
| EPS Growth Forecast (5Y) | 26.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 14.94 and a Piotroski F-Score of 5.
| Altman Z-Score | 14.94 |
| Piotroski F-Score | 5 |